Your shopping cart is currently empty

LH17 is a derivative of Kaempferol and serves as a potent and selective inhibitor of PDE4, with PDE4D2 IC50 at 73 nM and PDE4B2 IC50 at 190 nM. It demonstrates over 136-fold selectivity against other PDE isoenzymes (PDE1B/2A/3A/5A/8A/9A/10A) with IC50s greater than 10000 nM, except for PDE7A1 which has an IC50 of 300 nM. LH17 exhibits unique interactions with the M pocket of PDE4. In vitro and in vivo models show that LH17 has significant antifibrotic effects. This compound is applicable in the study of idiopathic pulmonary fibrosis (IPF).
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | LH17 is a derivative of Kaempferol and serves as a potent and selective inhibitor of PDE4, with PDE4D2 IC50 at 73 nM and PDE4B2 IC50 at 190 nM. It demonstrates over 136-fold selectivity against other PDE isoenzymes (PDE1B/2A/3A/5A/8A/9A/10A) with IC50s greater than 10000 nM, except for PDE7A1 which has an IC50 of 300 nM. LH17 exhibits unique interactions with the M pocket of PDE4. In vitro and in vivo models show that LH17 has significant antifibrotic effects. This compound is applicable in the study of idiopathic pulmonary fibrosis (IPF). |
| Targets&IC50 | PDE4D2:73 nM |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.